Clinical News: Page 54

CT body composition data prove useful for diagnosing metastatic NSCLC
By Kate Madden Yee
Body composition data from routine CT imaging helps clinicians diagnose, develop treatment, and predict outcomes of metastatic non-small cell lung cancer (mNSCLC).
January 8, 2025
Fat Tissue Adipocytes
Ultrasound ablation is effective for treating hyperparathyroidism
By Amerigo Allegretto
Ultrasound-guided thermal ablation techniques are safe and effective in treating patients with secondary hyperparathyroidism.
January 7, 2025
Ultrasound images depict a 63-year-old man who underwent radiofrequency ablation (RFA) for the treatment of secondary hyperparathyroidism. (A–D) 2D images show four hyperplastic parathyroid glands on the right and left sides (marked with crosshairs). The numbers near the crosshairs represent the number of measured trails. (E) Ultrasound-guided infusion of isolation fluid (arrowheads) around the hyperplastic parathyroid gland to protect vital organs such as the trachea (Tr), carotid arteries (CA), and recurrent laryngeal nerve pathway area (arrow). F) Ultrasound-guided RFA of the hyperplastic parathyroid gland. (G) Immediate postoperative contrast-enhanced ultrasound shows no contrast enhancement in the ablation area. The ablation procedures for the other three parathyroid glands were the same as those described above. Image courtesy of the RSNA,
PET scans can decrease unnecessary lymph node procedures
By Will Morton
Negative prostate-specific antigen PET scans can be used to avoid unnecessary pelvic lymph node dissection in certain prostate cancer patients undergoing radical prostatectomies.
January 7, 2025
Psma Pet
Breast MRI surveillance reduces disease recurrence
By Kate Madden Yee
In women with a personal history of breast cancer, postoperative MRI surveillance appears to lower their odds of advanced second breast cancer.
January 7, 2025
Mri Breast Cancer
PSMA-PET imaging spiked after FDA approval
By Will Morton
Rates of PET prostate cancer imaging increased rapidly after its approval by the U.S. Food and Drug Administration (FDA).
January 6, 2025
Prostate Imaging2
The challenges of dysrhythmic radiologists
By Paul McCoubrie, MBBS
In a new column, Paul McCoubrie, MBBS, discusses the characteristics of "dysrhythmic" radiologists.
January 3, 2025
Paul McCoubrie, MBBS.
Women with BRCA1/2 germline mutations are often denied breast MRI
By Kate Madden Yee
Women with BRCA1/2 germline mutations are often denied breast MRI -- despite the fact that the exam is recommended for this population.
January 3, 2025
Mri Breast Cancer
Starting breast cancer screening at 40 is more cost-effective
By Amerigo Allegretto
Starting breast cancer screening at age 40 is tied to improved patient outcomes and reduced healthcare spending on treatment.
January 3, 2025
Women Cancer Patient
PSMA-PET/CT bests conventional imaging for prostate cancer diagnosis
By Kate Madden Yee
PSMA-PET/CT bests conventional imaging when it comes to identifying high-risk, nonmetastatic, hormone-sensitive prostate cancer, researchers say.
January 3, 2025
Prostate Cancer
Deep learning plus DCE-MRI predicts breast cancer treatment response
By Amerigo Allegretto
A deep-learning system based on DCE-MRI can predict pathological complete response in breast cancer patients.
January 2, 2025
Mri Breast Cancer
Are patients satisfied with interventional radiology experiences?
By Will Morton
Interventional radiologists who excel in communication, positive outcomes, and cultural competence receive high patient ratings.
January 2, 2025
Interventional Radiology
2009 USPSTF guidelines not linked to higher breast cancer incidence
By Amerigo Allegretto
Breast cancer screening guidelines issued in 2009 have not led to increased or decreased breast cancer incidence.
December 27, 2024
Breast Cancer3 400 (2)
Previous Page
Page 54 of 3670
Next Page